Edwards Lifesciences Corporation (ETR:EWL)
Germany flag Germany · Delayed Price · Currency is EUR
69.99
-2.51 (-3.46%)
At close: Mar 6, 2026

Edwards Lifesciences Company Description

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.

It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.

The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve.

It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Edwards Lifesciences Corporation
Country United States
Founded 1958
Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Employees 16,000
CEO Bernard Zovighian

Contact Details

Address:
One Edwards Way
Irvine, California 92614
United States
Phone 949 250 2500
Website edwards.com

Stock Details

Ticker Symbol EWL
Exchange Deutsche Börse Xetra
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
SIC Code 3842

Key Executives

Name Position
Bernard Zovighian Chief Executive Officer
Scott Ullem Chief Financial Officer